Innate Pharma IPHA
NASDAQ IPHA
$1.57 -0.01 (-0.44%)
As of: Oct 21, 2026 · 10:41 AM EDT

Innate Pharma (IPHA) Buildings (2021)

Updated

Innate Pharma (IPHA) reported Buildings of $22,879 for the quarter ended Dec 31, 2021.

Analysis

Innate Pharma (IPHA) Buildings (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Innate Pharma 140.75 Mn -66.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 22,650.06
API Access

Innate Pharma Buildings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=buildings&ticker=IPHA&period=max&api_key=YOUR_API_KEY